James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 2,112 shares at $52.58 ($111K) on 2026-02-19, disclosed to the SEC on 2026-02-20.
Seasonal sale ($111k) by General Counsel and Secretary — this insider has traded CRSP in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CRSP | SELL | 2026-03-24 | $149K | — | Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |